TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34483453

Group type: COMPARATOR
Intervention: Placebo short-wave diathermy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Continuous short-wave diathermy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pulsed short-wave diathermy
Number of subjects: 90
Study: 36408818

Group type: EXPERIMENTAL
Intervention: HELENA-IR index scores for males
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: HELENA-IR index scores for females
Number of subjects: 1053
Study: 34195628

Group type: EXPERIMENTAL
Intervention: 30 tablets of hydrocodone (10 mg)–acetaminophen (325 mg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: 60 tablets of hydrocodone (10 mg)–acetaminophen (325 mg)
Number of subjects: 85
Study: 33503882

Group type: EXPERIMENTAL
Intervention: Smell and taste of milk before gastric tube feeds (n = 16)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No exposure (control group, n = 19)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Gastric tube feeds
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Smell of milk
Number of subjects: 35
Study: 32580739

Group type: EXPERIMENTAL
Intervention: Intermittent preventive therapy during pregnancy
Number of subjects: 228
Study: 33530956

Group type: EXPERIMENTAL
Intervention: Techniques for managing impacted fetal head at caesarean section
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Informed choice in trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive antenatal and postpartum education
Number of subjects: 0
Study: 32427120

Group type: EXPERIMENTAL
Intervention: omega-3 and cetirizine
Number of subjects: 52

Group type: COMPARATOR
Intervention: cetirizine
Number of subjects: 52
Study: 36216423

Group type: EXPERIMENTAL
Intervention: HABIT intervention delivered by trained Health Visitors
Number of subjects: 35
Study: 34028494

Group type: EXPERIMENTAL
Intervention: Online communication training for clinicians (3 sequential online educational modules and weekly text messages)
Number of subjects: 29206

Group type: EXPERIMENTAL
Intervention: Online communication training for clinicians
Number of subjects: 29206

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 29206
Study: 36216902

Group type: EXPERIMENTAL
Intervention: Interrupted suture technique (IST)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Continuous suture technique (CST)
Number of subjects: 332
Study: 34404983

Group type: EXPERIMENTAL
Intervention: Midazolam monotherapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: Midazolam plus fentanyl
Number of subjects: 129
Study: 35801782

Group type: EXPERIMENTAL
Intervention: WeChat-based caregiver education (WBCE) program
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control care (CC) group
Number of subjects: 170
Study: 34255136

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Taurine supplementation + exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Taurine supplementation
Number of subjects: 16
Study: 32176191

Group type: EXPERIMENTAL
Intervention: Do CHANGE 2 intervention (ambulatory health-behavior assessment technologies for 6 months combined with a 3-month behavioral intervention program)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 150
Study: 35841235

Group type: EXPERIMENTAL
Intervention: mRNA vaccine (M group; n = 43)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Viral vector vaccine (V group; n = 42)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: mRNA vaccine (M group)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Viral vector vaccine (V group)
Number of subjects: 85
Study: 34323924

Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/d) during chemoradiotherapy and afterward for up to 12 months
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (platinum-based chemotherapy with concurrent chest radiotherapy)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Metformin arm
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 54
Study: 34541752

Group type: EXPERIMENTAL
Intervention: Earplugs (between 10 pm and 7 am on the second night of ICU stay)
Number of subjects: 107

Group type: COMPARATOR
Intervention: No earplugs (control group)
Number of subjects: 107
Study: 32302009

Group type: EXPERIMENTAL
Intervention: 0.1 mmol kg-1 gadopiclenol
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.3 mmol kg-1 gadopiclenol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: 400 mg moxifloxacin
Number of subjects: 48
Study: 35583055

Group type: EXPERIMENTAL
Intervention: 100 mg 5-HTP daily
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Comparison between 5-HTP and placebo
Number of subjects: 61
Study: 33298762

Group type: EXPERIMENTAL
Intervention: Streptococcus salivarius K12 probiotic for 1 month
Number of subjects: 121

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 121
Study: 32698766

Group type: EXPERIMENTAL
Intervention: Individualized fluid management (IFM)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard fluid management (Control)
Number of subjects: 300
Study: 35489304

Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block (ESPB) with bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: No block (Control Group C)
Number of subjects: 40
Study: 33588377

Group type: EXPERIMENTAL
Intervention: Complex-Paired Training (CPT, n = 9)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Reverse-Contrast Training (RCT, n = 8)
Number of subjects: 17
Study: 32062860

Group type: EXPERIMENTAL
Intervention: Post-operative medication checklist
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (post-operative pain medication plus VAS form)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 36193575

Group type: EXPERIMENTAL
Intervention: Tacrolimus 4-hour monitoring (C4)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Trough monitoring (C0)
Number of subjects: 50
Study: 34267272

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (downhill walking) 3-5 times per week for 2 months
Number of subjects: 127

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 127
Study: 32605389

Group type: EXPERIMENTAL
Intervention: Contemporaneous transabdominal rigid ureteroscopy (TRU)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Postoperative extracorporeal shockwave lithotripsy (SWL)
Number of subjects: 45
Study: 35063244

Group type: EXPERIMENTAL
Intervention: Cranberry group (500 mg dry cranberry extract, 2 times daily for 2 months)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo group (500 mg corn starch, 2 times daily for 2 months)
Number of subjects: 25
Study: 34032479

Group type: EXPERIMENTAL
Intervention: Single-dose IV administration of MMF (2.5 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single-dose PO administration of MMF (5 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Long-term PO administration of MMF (5 mg/kg, PO, q 24 h for 30 days and then 5 mg/kg, PO, q 48 h for an additional 30 days)
Number of subjects: 12
Study: 35675525

Group type: EXPERIMENTAL
Intervention: Solithromycin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 97
Study: 35192970

Group type: EXPERIMENTAL
Intervention: Cisternostomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Decompressive Craniectomy
Number of subjects: 50
Study: 32344403

Group type: EXPERIMENTAL
Intervention: Unilateral Left Nostril Breathing (ULNB) for 15 min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Breath awareness for 15 min (Control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unilateral Left Nostril Breathing (ULNB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Breath awareness (Control)
Number of subjects: 20
Study: 34328481

Group type: EXPERIMENTAL
Intervention: SLA surface implants (Group 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fluorine-modified surface implants (Group 2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Anodized surface implants (Group 3)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparative analysis of all groups
Number of subjects: 37
Study: 33132344

Group type: EXPERIMENTAL
Intervention: 5 g RMD three times daily
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo beverage without RMD
Number of subjects: 140
Study: 36214230

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided trigger point injection (TPI)
Number of subjects: 196

Group type: COMPARATOR
Intervention: NSAID plus muscle relaxant (MR)
Number of subjects: 196
Study: 32666079

Group type: EXPERIMENTAL
Intervention: Canakinumab (CANTOS trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colchicine (COLCOT trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other anti-inflammatory treatments (e.g., methotrexate in Cardiovascular Inflammation Reduction Trial)
Number of subjects: 0
Study: 32957334

Group type: EXPERIMENTAL
Intervention: Upper limbs endurance strengthening (group E)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Upper limbs force strengthening (group F)
Number of subjects: 280
Study: 36167936

Group type: EXPERIMENTAL
Intervention: Multi-component intervention (neck exercises, health-promotion information, workplace ergonomics) over 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 120
Study: 33413874

Group type: EXPERIMENTAL
Intervention: Transanal tube insertion
Number of subjects: 157

Group type: COMPARATOR
Intervention: No transanal tube insertion
Number of subjects: 157
Study: 36138497

Group type: EXPERIMENTAL
Intervention: Group 1 (early stages)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group 2 (advanced stages)
Number of subjects: 20
Study: 35134961

Group type: EXPERIMENTAL
Intervention: Cartridge-based e-vapor product (classic, 4% nicotine)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Cartridge-based e-vapor product (menthol, 4% nicotine)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Cartridge-based e-vapor products (both tests)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control (continued smoking)
Number of subjects: 450
Study: 32130160

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) classifiers for nonmedical use
Number of subjects: 6860

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) classifiers for side effects
Number of subjects: 6860
Study: 35105251

Group type: EXPERIMENTAL
Intervention: Derotational breathing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Maximal breathing
Number of subjects: 24
Study: 33345573

Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 25

Group type: COMPARATOR
Intervention: No PET-CT
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: EHD
Number of subjects: 25
Study: 32798840

Group type: EXPERIMENTAL
Intervention: mNGF
Number of subjects: 60

Group type: COMPARATOR
Intervention: citicoline (control)
Number of subjects: 60
Study: 35855848

Group type: EXPERIMENTAL
Intervention: Flexible ureteroscopy
Number of subjects: 78
Study: 33687587

Group type: EXPERIMENTAL
Intervention: CPT1A rs2846194
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: CPT1A rs2602814
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: CPT1A rs59506005
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: GGAC haplotype (rs17399246 rs1016873 rs11228450 rs10896396)
Number of subjects: 334
Study: 35719613

Group type: EXPERIMENTAL
Intervention: pTNM staging system
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Age at diagnosis
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Nomograms based on pTNM, age, and tumor grade
Number of subjects: 236

Group type: COMPARATOR
Intervention: Comparison with Sheldon and Mayo staging systems
Number of subjects: 236
Study: 33932527

Group type: EXPERIMENTAL
Intervention: Gratitude writing intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control writing intervention
Number of subjects: 61
Study: 34224601

Group type: EXPERIMENTAL
Intervention: Acoustic subcision treatment
Number of subjects: 56
Study: 33479759

Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination scores (MMSE)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Performance status
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Chronological age
Number of subjects: 330
Study: 36967704

Group type: EXPERIMENTAL
Intervention: Previsit glaucoma video/question prompt list intervention
Number of subjects: 189

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 189
Study: 33581971

Group type: EXPERIMENTAL
Intervention: SOC + IPSP
Number of subjects: 399

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 399
Study: 35537314

Group type: EXPERIMENTAL
Intervention: Satralizumab (120 mg subcutaneous)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Steroid tapering
Number of subjects: 16

Group type: COMPARATOR
Intervention: Satralizumab
Number of subjects: 16
Study: 34120149

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 35240552

Group type: EXPERIMENTAL
Intervention: Pink noise
Number of subjects: 16

Group type: COMPARATOR
Intervention: White noise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Chaotic signals
Number of subjects: 16

Group type: COMPARATOR
Intervention: No-stimulation condition
Number of subjects: 16
Study: 32186272

Group type: EXPERIMENTAL
Intervention: Tree nuts and peanuts
Number of subjects: 0
Study: 35412564

Group type: EXPERIMENTAL
Intervention: Home-based walking exercise behavior change intervention
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 190
Study: 34116009

Group type: EXPERIMENTAL
Intervention: Evaluation of IOL rotational stability using nontoric implants in 25 patients with 2 consecutive follow-up visits.
Number of subjects: 25
Study: 32654212

Group type: EXPERIMENTAL
Intervention: Inotersen 300 mg weekly for 65 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35243125

Group type: EXPERIMENTAL
Intervention: Floating (resting in a supine immersed position on flotation devices)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: WATSU (a passive hands-on treatment in warm water)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spa session
Number of subjects: 24
Study: 32152774

Group type: EXPERIMENTAL
Intervention: Laparoscopic/robotic extraperitoneal paraaortic staging
Number of subjects: 634

Group type: COMPARATOR
Intervention: Imaging staging (control group)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Overall survival and cancer-specific disease-free survival
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Time interval between diagnosis and starting EFRT
Number of subjects: 634
Study: 616782981

Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia combined with nerve block
Number of subjects: 65
Study: 36198383

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard lymphadenectomy
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 170
Study: 34469764

Group type: EXPERIMENTAL
Intervention: Screening for atrial fibrillation
Number of subjects: 28768

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 28768
Study: 35596008

Group type: EXPERIMENTAL
Intervention: Canola Oil (CO)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Sesame–Canola Oil (SCO)
Number of subjects: 282
Study: 34890355

Group type: EXPERIMENTAL
Intervention: SWiPE app intervention
Number of subjects: 1309
Study: 34958176

Group type: EXPERIMENTAL
Intervention: Parent Participation in Postoperative Pain Management Program
Number of subjects: 413

Group type: COMPARATOR
Intervention: Routine postoperative pain management
Number of subjects: 413
Study: 32133503

Group type: EXPERIMENTAL
Intervention: Milk (600 mL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cheese (100 g)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Soy-based drink (600 mL)
Number of subjects: 11
Study: 36121672

Group type: EXPERIMENTAL
Intervention: Rituximab (500 mg intravenous infusion)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 87
Study: 34101234

Group type: EXPERIMENTAL
Intervention: 3-mm abutment
Number of subjects: 65

Group type: COMPARATOR
Intervention: 1-mm abutment
Number of subjects: 65
Study: 35797804

Group type: EXPERIMENTAL
Intervention: Immersive virtual reality rehabilitation (Oculus Rift), 12 sessions over 4 weeks
Number of subjects: 20
Study: 34314018

Group type: EXPERIMENTAL
Intervention: belantamab mafodotin (belamaf) 2.5 mg/kg
Number of subjects: 97
Study: 32891287

Group type: EXPERIMENTAL
Intervention: Interactive games
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Painting
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control
Number of subjects: 172
Study: 35371086

Group type: EXPERIMENTAL
Intervention: Prednisone + Methotrexate (MTX) 10 mg orally every week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prednisone + Methotrexate (MTX)
Number of subjects: 40
Study: 32346833

Group type: EXPERIMENTAL
Intervention: Reciproc (R25)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: K‐files (#15‐40)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: ProDesign Logic (#25)
Number of subjects: 81
Study: 32910201

Group type: EXPERIMENTAL
Intervention: Caprini RAM
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Khorana score (KS)
Number of subjects: 442
Study: 35714077

Group type: EXPERIMENTAL
Intervention: Tele-supervised home-based exercise training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 32
Study: 32167177

Group type: EXPERIMENTAL
Intervention: Forward conditioning with intense USs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Backward conditioning with intense USs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forward conditioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Backward conditioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Backward CSs with increasing US pleasantness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omission of forward CSs
Number of subjects: 0
Study: 33931736

Group type: EXPERIMENTAL
Intervention: Maternal voice exposure during neonatal NREM sleep
Number of subjects: 35

Group type: COMPARATOR
Intervention: Right hemisphere ICOH (C4-Cz; T4-Cz)
Number of subjects: 35
Study: 32845522

Group type: EXPERIMENTAL
Intervention: Gestational anaemia
Number of subjects: 182309

Group type: COMPARATOR
Intervention: Control group (no gestational anaemia)
Number of subjects: 182309
Study: 33096999

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted group
Number of subjects: 12

Group type: COMPARATOR
Intervention: Landmark-guided group
Number of subjects: 12
Study: 35469143

Group type: EXPERIMENTAL
Intervention: Barley-based remedy plus conventional medicine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study: 33333277

Group type: EXPERIMENTAL
Intervention: Self-transfusion with autologous blood transfusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no self-transfusion)
Number of subjects: 40
Study: 36235536

Group type: EXPERIMENTAL
Intervention: Whey protein (PRO‐HIIT, N = 24)
Number of subjects: 47
Study: 32949456

Group type: EXPERIMENTAL
Intervention: Individually prescribed home hazard reduction and home-based exercise program
Number of subjects: 309

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 309
Study: 36379530

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Corticosteroids (CS) injections
Number of subjects: 30
Study: 33644953

Group type: EXPERIMENTAL
Intervention: mXELIRI (capecitabine plus irinotecan) with PPI use
Number of subjects: 482

Group type: COMPARATOR
Intervention: FOLFIRI with PPI use
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: mXELIRI without PPI use
Number of subjects: 482

Group type: COMPARATOR
Intervention: FOLFIRI without PPI use
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: mXELIRI with PPI use
Number of subjects: 482
Study: 35288599

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg/kg every 6 hours, 6-12 hours prior to extubation (four doses)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 35750736

Group type: EXPERIMENTAL
Intervention: Behavioural intervention (theory-based programme)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Conventional programmes (control)
Number of subjects: 312
Study: 32747306

Group type: EXPERIMENTAL
Intervention: ORC-Coll (mediCipio® A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: CBFS (Tachosil®)
Number of subjects: 150
Study: 32909387

Group type: EXPERIMENTAL
Intervention: Standard provider-initiated-testing-and-counselling (PITC)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Optimized PITC (additional provider training and job-aids)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: FB-HIVST (HIVST demonstration, distribution and kit use in OPD, private kit interpretation and optional HIV counselling)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Optimized PITC
Number of subjects: 15

Group type: COMPARATOR
Intervention: FB-HIVST
Number of subjects: 15
Study: 35677588

Group type: EXPERIMENTAL
Intervention: Consultation audio-recordings with an interpreter and question prompt lists translated into Arabic, Greek, Traditional, and Simplified Chinese.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consultation audio-recordings with an interpreter and question prompt lists.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (feasibility study).
Number of subjects: 0
Study: 34074214

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) with 25 daily multi-donor FMT capsules for 12 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 0